MOUNJARO 5 MG / 0.5 ML
TIRZEPATIDE : 5 MG / 0.5 ML · DIN 02541068 · ELI LILLY CANADA INC
Health Canada status: MARKETED
What is MOUNJARO?
MOUNJARO 5 MG / 0.5 ML contains TIRZEPATIDE : 5 MG / 0.5 ML. It is listed in the Health Canada Drug Product Database under DIN 02541068, held by ELI LILLY CANADA INC, supplied as SOLUTION for SUBCUTANEOUS administration. Health Canada currently lists it as marketed, status dated 23-Oct-2023. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is MOUNJARO used for?
MOUNJARO (tirzepatide injection) is indicated for once-weekly administration as an adjunct to diet and exercise to improve glycemic control for the treatment of adult patients with type 2 diabetes mellitus. It can be used as monotherapy when metformin is inappropriate due to contraindication or intolerance, or in combination with metformin, metformin and a sulfonylurea, metformin and a sodium-glucose cotransporter 2 inhibitor (SGLT2i), or basal insulin with or without metformin.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02541068 |
|---|---|
| Brand name | MOUNJARO |
| Generic / active ingredient | TIRZEPATIDE : 5 MG / 0.5 ML |
| Manufacturer | ELI LILLY CANADA INC |
| Strength | 5 MG / 0.5 ML |
| Dosage form | SOLUTION |
| Route of administration | SUBCUTANEOUS |
| Schedule | Prescription |
| ATC code | A10BX16 TIRZEPATIDE |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 23-Oct-2023 |
How is it stored and handled?
null
How is it supplied?
Packs of 4 single-dose prefilled pens, or individual single-dose vial (for MOUNJARO); individual multi-dose prefilled pens (for MOUNJARO KwikPen)
What can be used instead?
Other Canadian products sharing ATC code A10BX16 TIRZEPATIDE. 18 of 24 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| MOUNJARO | 10 MG / 0.5 ML | SOLUTION | ELI LILLY CANADA INC | MARKETED | DIN 02541084 |
| MOUNJARO | 12.5 MG / 0.5 ML | SOLUTION | ELI LILLY CANADA INC | MARKETED | DIN 02541092 |
| MOUNJARO | 15 MG / 0.5 ML | SOLUTION | ELI LILLY CANADA INC | MARKETED | DIN 02541106 |
| MOUNJARO | 2.5 MG / 0.5 ML | SOLUTION | ELI LILLY CANADA INC | MARKETED | DIN 02541041 |
| MOUNJARO | 7.5 MG / 0.5 ML | SOLUTION | ELI LILLY CANADA INC | MARKETED | DIN 02541076 |
| MOUNJARO KWIKPEN | 10 MG / 0.6 ML | SOLUTION | ELI LILLY CANADA INC | MARKETED | DIN 02551985 |
| MOUNJARO KWIKPEN | 12.5 MG / 0.6 ML | SOLUTION | ELI LILLY CANADA INC | MARKETED | DIN 02551993 |
| MOUNJARO KWIKPEN | 15 MG / 0.6 ML | SOLUTION | ELI LILLY CANADA INC | MARKETED | DIN 02552000 |
| MOUNJARO KWIKPEN | 2.5 MG / 0.6 ML | SOLUTION | ELI LILLY CANADA INC | MARKETED | DIN 02551950 |
| MOUNJARO KWIKPEN | 5 MG / 0.6 ML | SOLUTION | ELI LILLY CANADA INC | MARKETED | DIN 02551969 |
Who else supplies TIRZEPATIDE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. TIRZEPATIDE appears in 81 registered pack listings across 8 markets, published on 6 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.